Publication:
Rosmarinic acid inhibits the proliferation of ovarian carcinoma cells by activating the p53/BAX signaling pathway

Simple item page
dc.contributor.authorÖzdemır İlhan
dc.contributor.authorDoğan Baş Dilek
dc.contributor.authorÖztürk Şamil
dc.contributor.authorKaraosmanoğlu Özge
dc.contributor.authorCudi Tuncer Mehmet
dc.contributor.departmentBiología Celular e Histología
dc.coverage.spatial,, , , ,
dc.date.accessioned2025-10-13T09:05:29Z
dc.date.available2025-10-13T09:05:29Z
dc.date.issued2025
dc.description.abstractObjective. While chemotherapeutic agents stop the development of cancer cells, they also kill healthy cells. This study aimed to increase anticancer effects and reduce side effects by combining a phytotherapeutic compound with a chemotherapeutic drug. Methods. This study examined the effects of nine concentrations of rosmarinic acid (RA) and doxorubicin (DOX) on human ovarian adenocarcinoma (OVCAR3) and skin keratinocyte (HaCaT) cell lines. Their cytotoxic effects were assessed based on cell viability, evaluated using the MTT assay, and apoptotic activity, evaluated using NucBlue staining and the gene and protein expression of tumor protein p53 (TP53) and BCL2 associated X, apoptosis regulator (BAX) quantified by qRT-PCR and western blots, respectively. Results. The half-maximal inhibitory concentration after 48 hours was 880.4 μM for RA and 2.26 μM for DOX. The cytotoxicity analysis revealed that cell viability decreased with the RA concentration. RA increased apoptosis in OVCAR3 cells by activating the p53/BAX pathway. Western blots showed that RA and DOX upregulated p53 and BAX protein levels in OVCAR3 cells. Conclusions. The RA and DOX combination inhibited cell proliferation by inducing apoptosis in OVCAR3 cells. These results suggest that RA may reduce the side effects of DOX toxicit
dc.formatapplication/pdf
dc.format.extent9
dc.identifier.citationHistology and Histopathology, Volúmen 40, nº 9 (2025)
dc.identifier.doihttps://doi.org/10.14670/HH-18-883
dc.identifier.eissn1699-5848
dc.identifier.issn0213-3911
dc.identifier.urihttp://hdl.handle.net/10201/166029
dc.languageeng
dc.publisherUniversidad de Murcia, Histología e Histopatología
dc.relationSin financiación externa a la Universidad
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectRosmarinic acid
dc.subjectOvarian cancer
dc.subjectOVCAR3
dc.subjectApoptosis
dc.subjectqRT-PCR
dc.subjectCell death
dc.subject.odsNo relacionado con ningún objetivo de desarrollo sostenible
dc.titleRosmarinic acid inhibits the proliferation of ovarian carcinoma cells by activating the p53/BAX signaling pathway
dc.typeinfo:eu-repo/semantics/article
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ozdemir-40-1415-1423-2025.pdf
Size:
11.01 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.37 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Histology and histopathology Vol.40, nº9 (2025)